INTRODUCTION
It is illegal to add unauthorized synthetic compounds to commercial functional foods with the intention of deceitfully advertizing their effectiveness as alternatives to conventional medicines.1 One of the chemicals to adulterate the functional foods was sildenafil citrate, the active ingredient of Viagra®approved to Pfizer for the treatment of male erectile dysfunction. Sildenafil (Ⅰ) is the inhibitor of phosphodiesterase-5 (PDE-5), the enzyme involved in the decomposition of c-GMP to contract smooth muscles inducing penile erectile dysfunction.2
While this medicine is active against the erectile dysfunction, it is not safe for patients of diabetes or hypertension with nitrate medications (e.g., nitroglycerin, isosorbide dinitrate), and taking these drugs at the same time could cause the blood pressure to drop drastically, thus the sildenafilcontaining drugs should not be obtained without doctor’s prescription.3 Therefore, in order to prevent the potential health risk caused by the misuse and overuse of sildenafil from the functional foods, it is necessary to check the presence of this pharmaceutical in commercial foods, and selective and simultaneous screening methods were developed by Korea Food and Drug Administration (KFDA) and others.4,5
Later, it was found that some food manufacturers and importers made alternative attempts to evade the screening system by adding other substances similar but not identical to sildenafil. The functional foods that contain these chemicals pose more serious health risk to consumers, since the safety of the sildenafil analogs to human body has not been established yet. Actually, one commercial herb drink was found recently to contain the sildenafil-like substance which was detected in high-performance liquid chromatography (HPLC) analysis. In order to identify the unknown illegal additive, separation and purification were performed and its chemical structure was determined by spectroscopic analysis, and here we report the results.
EXPERIMENTAL SECTION
General Procedures
Melting points were determined on a Thomas-Hoover Unimelt apparatus and are uncorrected. UV spectra were obtained on a Varian CARY 100, and IR spectra were taken on a Bruker IFS48 spectrometer using a thin liquid film of solution in chloroform and the data are presented as cm-1 for important diagnostic absorptions. NMR spectra were obtained on a Bruker Avance 400 spectrometer (400 and 100 MHz for 1H and 13C, respectively) in DMSO-d6, and chemical shifts are reported in δ scale in parts per million from tetramethylsilane as an internal standard. Electrospray ionization mass spectra (ESI-MS) were obtained from a VG Micromass, and data are reported in the form m/z (intensity relative to base peak = 100). Elemental microanalysis was performed on a CE Instrument EA1110. HPLC analysis data were obtained from a Waters 2690 separation module coupled to a 996 photodiode array detector. Thin-layer chromatography (TLC) was performed with E. Merck silica gel 60 F-254 precoated glass plates (0.25 mm). All solvents used for extraction and isolation were of HPLC grade purchased from Fisher Scientific.
Extraction and Isolation Procedures
The content of ten bottles of a commercial herb drink sample (30 mL/bottle) was mixed with 1% sodium bicarbonate solution (1 mL) and the mixture was extracted three times with methylene chloride (300 mL each). The organic layer was dried with anhydrous sodium sulfate and filtered, and the filtrate was concentrated in vacuo using a rotary evaporator. The residue was dissolved in methanol (15 mL), and after filtration through membrane filter, the solution was purified by semipreparative HPLC on μBondapak C18 column (7.8 × 300 mm, 5 μm) using acetonitrile-watertrifluoroacetic acid (90:10:0.1) as eluent with a flow rate of 5 mL/min. The collected fractions were freeze-dried to give 20 mg of the purified unknown compound.
Characterization of the Isolated Compound
Colorless crystal: mp 194 - 196 ℃; UV λmax (Ethanol) 220, 293 nm; IR (CHCl3) 3314 (w), 2955 (w), 1696 (s), 1595 (w), 1490 (w), 1394 (w), 1350 (w), 1166 (m), 952 (w), 740 (w); 1H and 13C NMR, DEPT, COSY, and HMBC (Table 1); Mass m/z 505 (M+1, 100), 486 (23), 445 (21), 404 (31), 377 (35), 312 (81), 283 (29), 129 (29), 99 (53).
Anal. Calcd for C23H32N6O5S: C, 54.75; H, 6.39; N, 16.65; S, 6.35. Found C, 54.74; H, 6.39; N, 16.76; S, 6.51.
RESULTS AND DISCUSSION
HPLC analysis was generally used to screen the illegal additives in commercial functional foods, and the solvent program for this investigation was a gradient system: “A”, acetonitrile (95%), and “B”, water with 0.1% sodium 1-hexanesulfonate and 0.1% phosphoric acid, with the ratio of “A” to “B” from 7:3 to 2:8.6 According to this HPLC analysis of a commercial herb drink on a C18 reversed-phase column (4.6 × 250 mm, 5 μm), previously undeclared compound was detected at the retention time of 23.8 min, which was close to that of sildenafil (25.3 min). Further, after the isolation and purification of this compound, the UV spectrum in methanolic solution showed λmax at 220 and 293 nm, which was identical to that of sildenafil. Thus, this compound was believed to be similar to sildenafil in chemical structure and physical property.
The chemical structure of this compound was determined by IR, MS, and NMR spectroscopy. IR spectrum showed absorption bands characteristic of hydroxyl (3314 cm-1), amide (1696 cm-1), aromatic (1595, 1490 cm-1), and sulfonamide group (1350, 1166 cm-1). The molecular structure of the unknown substance was further analyzed by LC/MS-ESI in the positive-ion mode and fragmentation patterns, which exhibit [M+H]+ of 505 with fragments at m/z 404, 312, and 129 (Fig. 1). This mass spectrum was similar to that of sildenafil ([M+H]+ of 475 with fragments at m/z 404, 312, and 99), and the only difference in MS between this unknown compound and sildenafil was 30 mass units in the protonated molecular ions of 505 vs. 475 and fragments 129 vs. 99. This 30 amu difference was believed to arise from the presence of hydroxyethyl (HOCH2CH2-) instead of methyl (CH3-) group of sildenafil.
Fig. 1.Mass spectrum of the sildenafil analogue. The fragment peaks at m/z 312 and 129 were assigned as indicated in the structure shown.
1D NMR (1H-NMR, 13C-NMR, and DEPT) and 2D NMR (COSY and HMBC) spectra of this compound were obtained and listed in Table 1, wherein the numbering system of the compound is given in Fig. 2. 1H-NMR spectrum (Fig. 3) showed characteristics of amide at δ 12.23 (1H, br); methyl group attached to nitrogen at δ 4.16 (3H, s); propyl group at δ 2.77, 1.74, and 0.94; three aromatic protons with 1,2,4-orientation at δ 7.85 (1H, d), 7.82 (1H, dd), and 7.38 (1H, d); ethoxy group at δ 4.21 (2H, q) and 1.33 (3H, t); two methylene groups of the piperazine ring at δ 2.88 (4H, br) and 2.48 (4H, br); and hydroxyethyl group at δ 2.36 (2H, t), 3.42 (2H, t), and 4.39 (OH, br). There are 21 peaks in 13C-NMR spectrum, and DEPT experiment shows three methyl groups, seven methylene groups, three methine groups, and eight quarternary carbons. Eleven peaks in the downfield region were assigned to carbons of benzene ring and pyrazolopyrimidinone ring. Six peaks in the range of δ 35 ~ 65 were assigned to carbons connected to oxygen or nitrogen as follows: methyl group attached to nitrogen at δ 37.9, methylene of the ethoxy group at δ 64.9, methylene carbons of the piperazine ring at δ 45.9 and 51.9, and hydroxyethyl group connected to the piperazine ring at δ 58.4 and 59.5. Four peaks in the upfield region were assigned to propyl carbons (δ 27.2, 21.7 and 13.9) and methyl carbon of the ethoxy group (δ 14.3). This peak assignment was further supported by 2D NMR techniques: 1H-1H homonuclear COSY and 13C-1H heteronuclear HMBC as indicated in Table 1.
Fig. 2.The chemical structure and numbering system of the sildenafil analogue.
Fig. 3.1H-NMR spectrum of the sildenafil analogue.
Table 1.The NMR spectral data of the sildenafil analogue.
These 1H- and 13C-NMR spectra were compared to those of sildenafil, and they were similar each other except hydroxyethyl group of the unknown compound vs. methyl group of sildenafil as follows: δ 2.36 (2H, t), 3.42 (2H, t) and 4.39 (1H, br) of hydroxyethyl vs. δ 2.12 (3H, s) of methyl group in 1H-NMR; and δ 58.4 and 59.5 of hydroxyethyl vs. δ 44.3 of methyl group in 13C-NMR.
In order to confirm the chemical structure of the isolated compound further, it was synthesized according to the literature,7 and all the spectral data of the synthesized compound were completely identical to those of the purified substance from the herb drink. The synthesized compound is now used as a standard sample in detecting the presence of pharmaceuticals that are illegally added to commercial herb drinks and tablets.
CONCLUSION
In summary, previously undeclared compound was detected from the HPLC analysis of a commercial herb drink marketed as a functional food, and the unknown additive was isolated from the herb drink by extraction with methylene chloride and purification using semipreparative HPLC. The chemical structure of the isolated substance was identified from UV, IR, MS, and NMR spectroscopic analysis to be sildenafil analog with minor change of methyl group to hydroxyethyl group at the piperazine ring. The compound was synthesized in order to use as a standard sample in the inspection of the drinks and tablets sold as functional foods for the presence of illegal additives.
References
- Food Sanitation Act (Republic of Korea), Article 6 (Prohibition of Sale, etc. of Chemical Synthetic Compounds, etc. without Notice of Criteria and Standards).
- Terrett, N. K.; Bell, A. S.; Brown, D.; Ellis, P. Bioorg. Med. Chem. Lett. 1996, 1819.
- Boolell, M.; Allen, M. J.; Ballard, S. A.; Gepi-Attee, S.; Muirhead, G. J.; Naylor, A. M.; Osterloh, I. H.; Gingell, C. Int. J. of Impotence Res. 1996, 8, 47.
- Webb, D. J.; Freestone, S.; Allen, M. J.; Muirhead, G. J. Am. J. Cardiol. 1999, 83, 21C.
- Jang, J.; Park, K.; Park, H.; Koo, Y.; Choi, Y.; Hwang, I. K.; Kim, D. J. Fd. Hyg. Safety 2003, 18, 195.
- Graz, S. R.; Flurer, C. L.; Wolnik, K. A. J. Pharm. Biomed. Anal. 2004, 36, 525. https://doi.org/10.1016/j.jpba.2004.07.004
- Manual for the Determination of Illegal Compounds in Foods (Publication Number 11-1470000-00839-14), Korea Food and Drug Administration (2005).
- Bell, A. S.; Brown, D.; Terrett, N. K. Pyrazolopyrimidinone antianginal agents, Eur. Pat. Appl. 463756 A1, Jan. 02, 1992.